Cargando…
Upregulation of microRNA-524-5p enhances the cisplatin sensitivity of gastric cancer cells by modulating proliferation and metastasis via targeting SOX9
Cisplatin-based chemotherapy is the most commonly used treatment regimen for gastric cancer (GC), however, the resistance to cisplatin represents the key limitation for the therapeutic efficacy. Aberrant expression of MiR-524-5p appears to be involves in tumorigenesis and chemoresistance. However, t...
Autores principales: | Wang, Jing, Xue, Xiaofeng, Hong, Han, Qin, Mingde, Zhou, Jin, Sun, Qing, Liang, Hansi, Gao, Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352179/ https://www.ncbi.nlm.nih.gov/pubmed/27880941 http://dx.doi.org/10.18632/oncotarget.13479 |
Ejemplares similares
-
MicroRNA-524 promotes cell proliferation by down-regulating PTEN expression in osteosarcoma
por: Zhuang, Ming, et al.
Publicado: (2018) -
Upregulation of microRNA-1 inhibits proliferation and metastasis of breast cancer
por: Peng, Jing, et al.
Publicado: (2020) -
EZH2 alteration driven by microRNA-524-5p and microRNA-324-5p promotes cell proliferation and temozolomide resistance in glioma
por: Zhi, Tongle, et al.
Publicado: (2017) -
MicroRNA-101 inhibits proliferation, migration and invasion of human glioblastoma by targeting SOX9
por: Liu, Nan, et al.
Publicado: (2016) -
MicroRNA-21 Increases Proliferation and Cisplatin Sensitivity of Osteosarcoma-Derived Cells
por: Vanas, Vanita, et al.
Publicado: (2016)